"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"

Starts:
1:45 pm on Friday, October 12, 2012
Ends:
2:45 pm on Friday, October 12, 2012
Location:
670 Albany Street Room #107/108
URL:
http://www.bumc.bu.edu/busm-pathology/files/2008/09/Seminar-Fall-2012.pdf
Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD Director of Developmental Therapeutics Massachusetts General Hospital Cancer Center Harvard Medical School